Features: |
Silver NanoParticles Summary: 1. Smaller sizes desirable due to greater surface area, and cell penetration (enhanced permeability and retention (EPR) effect) 2. Two main types: AgNP and silver ions (big debate on uses: Ag+ turning to AgCl in stomach but AgCl also effective. Take sodium-bicarbonate? 3. Dose example 80kg person: 1.12-2mg/day, which can be calculated based on ppm and volume taken (see below) target < 10ppm and 120mL per day (30ppm and 1L per day caused argyria 30mg/day ) (Case Report: 9‐15 ppm@120mL, i.e. 1.1mg/L to 1.8mg/L per day) Likely 10ppm --> 10mg/L, hence if take 100mL, then 1mg/day? (for Cancer) The current Rfd for oral silver exposure is 5 ug/kg/d with a critical dose estimated at 14 ug/kg/d for the average person. Seems like the Cancer target range is 14ug/kg/day to 25ug/kg/day. 80Kg example: 1.12mg to 2mg “1.4µg/kg body weight. If I would have 70kg, I would want to use 100µg/day. However, for fighting active disease, I would tend to explore higher daily dose, as I think this may be too low.” 4. AntiOxidants/NAC can counter act the effect of Silver NanoParticles from producing reactive oxygen species (ROS) and mitochondrial damage . NAC is a supplement form of cysteine, an amino acid that helps make glutathione, a powerful antioxidant. 5. In vitro most reports indicate AgNPs increase ROS in both cancer and normal cell (but in vivo improved antioxidant system of normal may create selectivity) 6. Pathways/mechanisms of action/: -” intracellular ROS was increased...reduction in levels of glutathione (GSH)” -”AgNPs affect the function of the vascular endothelial growth factor (VEGF)” (likely reducing levels) -”expression of BAX and BCL2 genes was increased” -”upregulation of proapoptotic genes (p53, p21, Bax, and caspases) and downregulation of antiapoptotic genes (Bcl-2)” -” upregulation of AMPK and downregulation of mTOR, MMP-9, BCL-2, and α-SMA” -”p53 is a key player...proapoptotic genes p53 and Bax were significantly increased... noticeable reduction in Bcl-2 transcript levels” -” p53 participates directly in the intrinsic apoptosis pathway by regulating the mitochondrial outer membrane permeabilization” - “Proapoptotic markers (BAX/BCL-XL, cleaved poly(ADP-ribose) polymerase, p53, p21, and caspases 3, 8 and 9) increased.” -”The antiapoptotic markers, AKT and NF-kB, decreased in AgNP-treated cells.” Silver NanoParticles and Magnetic Fields Summary: 1. “exposure to PMF increased the ability of AgNPs uptake” 2. 6x improvement from AgNPs alone could glucose capping of SilverNPs work as trojan horse? |
664- | EGCG,  | SNP,  |   | Epigallocatechin-3-gallate-capped Ag nanoparticles: preparation and characterization |
- | Analysis, | NA, | NA |
2833- | FIS,  | SNP,  |   | Glucose-capped fisetin silver nanoparticles induced cytotoxicity and ferroptosis in breast cancer cells: A molecular perspective |
- | in-vitro, | BC, | MDA-MB-231 |
1904- | GoldNP,  | SNP,  |   | Unveiling the Potential of Innovative Gold(I) and Silver(I) Selenourea Complexes as Anticancer Agents Targeting TrxR and Cellular Redox Homeostasis |
- | in-vitro, | Lung, | H157 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Melanoma, | A375 |
848- | Gra,  | SNP,  |   | Synthesis, Characterization and Evaluation of Antioxidant and Cytotoxic Potential of Annona muricata Root Extract-derived Biogenic Silver Nanoparticles |
- | in-vitro, | CRC, | HCT116 |
853- | Gra,  | SNP,  |   | Solid lipid nanoparticles of Annona muricata fruit extract: formulation, optimization and in vitro cytotoxicity studies |
- | vitro+vivo, | AML, | THP1 | - | in-vitro, | AML, | AMJ13 | - | vitro+vivo, | lymphoma, | HBL |
861- | Lae,  | Chit,  | SNP,  |   | Synthesis of polygonal chitosan microcapsules for the delivery of amygdalin loaded silver nanoparticles in breast cancer therapy |
323- | Sal,  | SNP,  |   | Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Ovarian, | A2780S |
397- | SNP,  | GEM,  |   | Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment |
- | in-vitro, | Ovarian, | A2780S |
390- | SNP,  |   | Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | BC, | NA |
391- | SNP,  |   | Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells |
392- | SNP,  |   | Biogenic silver nanoparticles synthesized from Piper longum fruit extract inhibit HIF-1α/VEGF mediated angiogenesis in prostate cancer cells |
393- | SNP,  |   | Green synthesized plant-based silver nanoparticles: therapeutic prospective for anticancer and antiviral activity |
- | in-vitro, | NA, | HCT116 |
394- | SNP,  |   | Anticancer activity of Moringa oleifera mediated silver nanoparticles on human cervical carcinoma cells by apoptosis induction |
- | in-vitro, | Cerv, | HeLa |
395- | SNP,  |   | The apoptotic and genomic studies on A549 cell line induced by silver nitrate |
- | in-vitro, | Lung, | A549 |
396- | SNP,  |   | Systemic Evaluation of Mechanism of Cytotoxicity in Human Colon Cancer HCT-116 Cells of Silver Nanoparticles Synthesized Using Marine Algae Ulva lactuca Extract |
- | in-vitro, | Colon, | HCT116 |
388- | SNP,  |   | Apoptotic efficacy of multifaceted biosynthesized silver nanoparticles on human adenocarcinoma cells |
- | in-vitro, | BC, | MCF-7 |
398- | SNP,  |   | Silver nanoparticles induced testicular damage targeting NQO1 and APE1 dysregulation, apoptosis via Bax/Bcl-2 pathway, fibrosis via TGF-β/α-SMA upregulation in rats |
- | in-vivo, | Testi, | NA |
399- | SNP,  | SIL,  |   | Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells |
- | in-vitro, | CRC, | HT-29 |
389- | SNP,  | Citrate,  |   | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
- | in-vitro, | BC, | MCF-7 |
374- | SNP,  |   | Silver nanoparticles selectively treat triple‐negative breast cancer cells without affecting non‐malignant breast epithelial cells in vitro and in vivo |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
387- | SNP,  |   | Silver nanoparticles induce mitochondria-dependent apoptosis and late non-canonical autophagy in HT-29 colon cancer cells |
- | in-vitro, | Colon, | HT-29 |
386- | SNP,  | Tam,  |   | Synergistic anticancer effects and reduced genotoxicity of silver nanoparticles and tamoxifen in breast cancer cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
385- | SNP,  |   | Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment |
- | in-vitro, | Hepat, | HepG2 | - | in-vitro, | Hepat, | WI38 |
384- | SNP,  |   | Dual functions of silver nanoparticles in F9 teratocarcinoma stem cells, a suitable model for evaluating cytotoxicity- and differentiation-mediated cancer therapy |
- | in-vitro, | Testi, | F9 |
383- | SNP,  |   | In vitro and in vivo evaluation of anti-tumorigenesis potential of nano silver for gastric cancer cells |
- | in-vitro, | GC, | MKN45 |
382- | SNP,  |   | Investigation the apoptotic effect of silver nanoparticles (Ag-NPs) on MDA-MB 231 breast cancer epithelial cells via signaling pathways |
- | in-vitro, | BC, | MDA-MB-231 |
381- | SNP,  |   | Silver Nanoparticles Exert Apoptotic Activity in Bladder Cancer 5637 Cells Through Alteration of Bax/Bcl-2 Genes Expression |
- | in-vitro, | Bladder, | 5637 |
380- | SNP,  | QC,  | CA,  | Chit,  |   | Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities |
- | in-vitro, | MG, | U118MG |
379- | SNP,  |   | Effects of green-synthesized silver nanoparticles on lung cancer cells in vitro and grown as xenograft tumors in vivo |
- | in-vivo, | Lung, | H1299 |
378- | SNP,  |   | Antitumor efficacy of silver nanoparticles reduced with β-D-glucose as neoadjuvant therapy to prevent tumor relapse in a mouse model of breast cancer |
- | ex-vivo, | BC, | 4T1 |
377- | SNP,  |   | Anticancer Action of Silver Nanoparticles in SKBR3 Breast Cancer Cells through Promotion of Oxidative Stress and Apoptosis |
- | in-vitro, | BC, | SkBr3 |
376- | SNP,  |   | Antitumor activity of colloidal silver on MCF-7 human breast cancer cells |
- | in-vitro, | BC, | MCF-7 |
375- | SNP,  | ALA,  |   | Alpha-Lipoic Acid Prevents Side Effects of Therapeutic Nanosilver without Compromising Cytotoxicity in Experimental Pancreatic Cancer |
- | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vivo, | NA, | NA |
373- | SNP,  |   | Cytotoxic Potential and Molecular Pathway Analysis of Silver Nanoparticles in Human Colon Cancer Cells HCT116 |
- | in-vitro, | Colon, | HCT116 |
1909- | SNP,  |   | The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase |
- | in-vivo, | Nor, | NA |
2837- | SNP,  |   | Trojan-Horse Mechanism in the Cellular Uptake of Silver Nanoparticles Verified by Direct Intra- and Extracellular Silver Speciation Analysis |
- | in-vitro, | NA, | NA |
2836- | SNP,  | Gluc,  |   | Glucose capped silver nanoparticles induce cell cycle arrest in HeLa cells |
- | in-vitro, | Cerv, | HeLa |
2835- | SNP,  | Gluc,  |   | Carbohydrate functionalization of silver nanoparticles modulates cytotoxicity and cellular uptake |
- | in-vitro, | Liver, | HepG2 |
2834- | SNP,  | Gluc,  |   | Electrochemical oxidation of glucose on silver nanoparticle-modified composite electrodes |
- | Study, | NA, | NA |
2539- | SNP,  | SDT,  |   | Combined effect of silver nanoparticles and therapeutical ultrasound on ovarian carcinoma cells A2780 |
- | in-vitro, | Melanoma, | A2780S |
2538- | SNP,  | SDT,  | Z,  |   | Dual-functional silver nanoparticle-enhanced ZnO nanorods for improved reactive oxygen species generation and cancer treatment |
- | Study, | Var, | NA | - | vitro+vivo, | NA, | NA |
2288- | SNP,  |   | Silver Nanoparticle-Mediated Cellular Responses in Various Cell Lines: An in Vitro Model |
- | Review, | Var, | NA |
2287- | SNP,  |   | Silver nanoparticles induce endothelial cytotoxicity through ROS-mediated mitochondria-lysosome damage and autophagy perturbation: The protective role of N-acetylcysteine |
- | in-vitro, | Nor, | HUVECs |
2286- | SNP,  |   | Short-term changes in intracellular ROS localisation after the silver nanoparticles exposure depending on particle size |
- | in-vitro, | Nor, | 3T3 |
2208- | SNP,  |   | Sepsis diagnosis and treatment using nanomaterials |
- | Review, | NA, | NA |
2207- | SNP,  | TQ,  |   | Protective effects of Nigella sativa L. seeds aqueous extract-based silver nanoparticles on sepsis-induced damages in rats |
- | in-vivo, | Nor, | NA |
- | in-vivo, | Nor, | NA |
2205- | SNP,  |   | Potential protective efficacy of biogenic silver nanoparticles synthesised from earthworm extract in a septic mice model |
- | in-vivo, | Nor, | NA |
- | in-vitro, | Laryn, | HEp2 |
1908- | SNP,  |   | Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase |
- | in-vitro, | Lung, | A549 |
1907- | SNP,  | GoldNP,  | Cu,  |   | In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands |
- | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Colon, | HCT15 | - | in-vitro, | Cerv, | HeLa |
1906- | SNP,  | GoldNP,  | Cu,  |   | Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors |
- | Review, | Var, | NA |
1905- | SNP,  |   | Evaluation of the effect of silver and silver nanoparticles on the function of selenoproteins using an in-vitro model of the fish intestine: The cell line RTgutGC |
- | in-vivo, | Nor, | NA |
- | in-vitro, | Lung, | U1285 |
1902- | SNP,  |   | Modulation of the mechanism of action of antibacterial silver N-heterocyclic carbene complexes by variation of the halide ligand |
- | in-vitro, | NA, | NA |
1594- | SNP,  | Citrate,  |   | Silver Citrate Nanoparticles Inhibit PMA-Induced TNFα Expression via Deactivation of NF-κB Activity in Human Cancer Cell-Lines, MCF-7 |
- | in-vitro, | BC, | MCF-7 |
1406- | SNP,  |   | The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition |
- | in-vivo, | Nor, | NA |
888- | SNP,  |   | Antibacterial Effects of Silver Nanoparticles on the Bacterial Strains Isolated from Catheterized Urinary Tract Infection Cases |
- | in-vivo, | UTI, | NA |
887- | SNP,  |   | Antibacterial potential of silver nanoparticles against isolated urinary tract infectious bacterial pathogens |
- | in-vitro, | UTI, | NA |
403- | SNP,  | RF,  |   | Synergetic effects of silver and gold nanoparticles in the presence of radiofrequency radiation on human kidney cells |
- | in-vitro, | NA, | HNK |
- | in-vitro, | BC, | MCF-7 |
328- | SNP,  | Rad,  |   | Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma |
- | vitro+vivo, | GBM, | U251 |
342- | SNP,  |   | Silver nanoparticles; a new hope in cancer therapy? |
- | Review, | NA, | NA |
341- | SNP,  |   | Bioprospecting a native silver-resistant Bacillus safensis strain for green synthesis and subsequent antibacterial and anticancer activities of silver nanoparticles |
- | in-vitro, | Liver, | HepG2 |
340- | SNP,  |   | Screening bioactivities of Caesalpinia pulcherrima L. swartz and cytotoxicity of extract synthesized silver nanoparticles on HCT116 cell line |
- | in-vitro, | CRC, | HCT116 |
339- | SNP,  |   | Cancer cell specific cytotoxic potential of the silver nanoparticles synthesized using the endophytic fungus, Penicillium citrinum CGJ-C2 |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | Melanoma, | A431 | - | in-vitro, | HCC, | HepG2 |
338- | SNP,  |   | Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer |
- | vitro+vivo, | Bladder, | 5637 |
337- | SNP,  | immuno,  |   | Silver nanoparticle induced immunogenic cell death can improve immunotherapy |
- | Review, | NA, | NA |
336- | SNP,  | PDT,  |   | Photodynamic ability of silver nanoparticles in inducing cytotoxic effects in breast and lung cancer cell lines |
- | in-vitro, | BC, | MCF-7 |
335- | SNP,  | PDT,  |   | Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy |
- | Review, | NA, | NA |
334- | SNP,  |   | Silver-Based Nanoparticles Induce Apoptosis in Human Colon Cancer Cells Mediated Through P53 |
- | in-vitro, | Colon, | HCT116 |
333- | SNP,  | HPT,  |   | Enhancement effect of cytotoxicity response of silver nanoparticles combined with thermotherapy on C6 rat glioma cells |
- | in-vivo, | GBM, | NA |
332- | SNP,  | Rad,  |   | Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy |
- | in-vivo, | GBM, | NA |
331- | SNP,  | Rad,  |   | Silver nanoparticles: a novel radiation sensitizer for glioma? |
- | vitro+vivo, | GBM, | NA |
330- | SNP,  | Rad,  |   | Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs |
- | in-vitro, | GBM, | U251 |
329- | SNP,  | Rad,  |   | Enhancement of radiotherapy efficacy by silver nanoparticles in hypoxic glioma cells |
- | in-vitro, | GBM, | U251 |
343- | SNP,  |   | Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma |
- | in-vitro, | PC, | PANC1 |
327- | SNP,  | MS-275,  |   | Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells |
- | in-vitro, | Lung, | A549 |
326- | SNP,  | TSA,  |   | Modulating chromatin structure and DNA accessibility by deacetylase inhibition enhances the anti-cancer activity of silver nanoparticles |
- | in-vitro, | Cerv, | HeLa |
325- | SNP,  |   | Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer |
324- | SNP,  | CPT,  |   | Silver Nanoparticles Potentiates Cytotoxicity and Apoptotic Potential of Camptothecin in Human Cervical Cancer Cells |
- | in-vitro, | Cerv, | HeLa |
322- | SNP,  | Cisplatin,  |   | Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin |
- | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | OVCAR-3 |
321- | SNP,  |   | I-131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery |
- | in-vivo, | NA, | NA |
320- | SNP,  |   | Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish |
- | vitro+vivo, | NA, | HUH7 |
319- | SNP,  |   | Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis |
318- | SNP,  |   | Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells |
- | in-vitro, | Pca, | PC3 |
317- | SNP,  |   | Autophagic effects and mechanisms of silver nanoparticles in renal cells under low dose exposure |
- | in-vitro, | Kidney, | HEK293 |
316- | SNP,  |   | Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells |
- | in-vitro, | BC, | MCF-7 |
312- | SNP,  | wortm,  |   | Inhibition of autophagy enhances the anticancer activity of silver nanoparticles |
- | vitro+vivo, | NA, | HeLa |
309- | SNP,  |   | Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells |
- | in-vitro, | NA, | A431 |
306- | SNP,  |   | Cancer Therapy by Silver Nanoparticles: Fiction or Reality? |
- | Analysis, | NA, | NA |
358- | SNP,  |   | Preparation of triangular silver nanoparticles and their biological effects in the treatment of ovarian cancer |
- | vitro+vivo, | Ovarian, | SKOV3 |
- | in-vitro, | Hepat, | HepG2 |
371- | SNP,  |   | Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549 |
- | in-vitro, | Lung, | A549 |
370- | SNP,  |   | Differential genotoxicity mechanisms of silver nanoparticles and silver ions |
- | in-vitro, | lymphoma, | TK6 |
369- | SNP,  |   | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
- | in-vitro, | Liver, | NA |
368- | SNP,  |   | In vitro evaluation of silver nanoparticles on human tumoral and normal cells |
- | in-vitro, | Var, | NA |
367- | SNP,  |   | Presence of an Immune System Increases Anti-Tumor Effect of Ag Nanoparticle Treated Mice |
- | in-vivo, | NA, | NA |
366- | SNP,  |   | Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis |
- | in-vitro, | BC, | MCF-7 |
365- | SNP,  |   | Silver nanoparticles affect glucose metabolism in hepatoma cells through production of reactive oxygen species |
- | in-vitro, | Hepat, | HepG2 |
364- | SNP,  |   | Differential Action of Silver Nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) Activity in Mammalian Cell Lines |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Hepat, | HepG2 | - | in-vitro, | CRC, | SW-620 |
363- | SNP,  |   | Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis |
362- | SNP,  |   | Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer |
- | vitro+vivo, | SCC, | SCC9 |
361- | SNP,  |   | Annona muricata assisted biogenic synthesis of silver nanoparticles regulates cell cycle arrest in NSCLC cell lines |
- | in-vitro, | Lung, | A549 |
360- | SNP,  | Moringa,  |   | Cytotoxic and Genotoxic Evaluation of Biosynthesized Silver Nanoparticles Using Moringa oleifera on MCF-7 and HUVEC Cell Lines |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | HUVECs |
359- | SNP,  |   | Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HEK293 |
305- | SNP,  |   | Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer |
- | Case Report, | HNSCC, | NA |
357- | SNP,  |   | Hypoxia-mediated autophagic flux inhibits silver nanoparticle-triggered apoptosis in human lung cancer cells |
- | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | L132 |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | Bladder, | HTB-22 |
355- | SNP,  |   | Cytotoxicity and Genotoxicity of Biogenic Silver Nanoparticles in A549 and BEAS-2B Cell Lines |
- | in-vitro, | Lung, | A549 | - | in-vitro, | NA, | BEAS-2B |
- | in-vitro, | neuroblastoma, | SH-SY5Y |
353- | SNP,  |   | The mechanism of cell death induced by silver nanoparticles is distinct from silver cations |
- | in-vitro, | BC, | SUM159 |
352- | SNP,  |   | Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the crude extract of Syzygium aromaticum |
- | in-vitro, | BC, | MCF-7 |
351- | SNP,  |   | Study of antitumor activity in breast cell lines using silver nanoparticles produced by yeast |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | T47D |
350- | SNP,  |   | Cytotoxic and Apoptotic Effects of Green Synthesized Silver Nanoparticles via Reactive Oxygen Species-Mediated Mitochondrial Pathway in Human Breast Cancer Cells |
- | in-vitro, | BC, | MCF-7 |
349- | SNP,  |   | Insight into the molecular mechanism, cytotoxic, and anticancer activities of phyto-reduced silver nanoparticles in MCF-7 breast cancer cell lines |
- | in-vitro, | BC, | MCF-7 |
- | in-vitro, | BC, | MCF-7 |
347- | SNP,  |   | The Role of Silver Nanoparticles in the Diagnosis and Treatment of Cancer: Are There Any Perspectives for the Future? |
- | Review, | NA, | NA |
346- | SNP,  | RSQ,  |   | Investigating Silver Nanoparticles and Resiquimod as a Local Melanoma Treatment |
- | in-vivo, | Melanoma, | SK-MEL-28 | - | in-vivo, | Melanoma, | WM35 |
345- | SNP,  |   | Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model |
- | vitro+vivo, | lymphoma, | NA |
344- | SNP,  |   | Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells |
- | in-vitro, | Liver, | HepG2 |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:153 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid